Inmune Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.12

-0.08 (-6.67%)

As of Mar 29, 10:51 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +1,406.3% upside

Low Target $11.09

Average Target $16.87

High Target $25.84

Current Price $1.12

Current
$1.12

Target
$16.87

$11.09 $16.87 avg $25.84

Scenario Analysis

Bear Case

$11.09

890.2%

Low target

Base Case

$16.87

+1,406.3%

Avg target

Bull Case

$25.84

+2,207.1%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$11.64

-90.4% from high

52-Week Low

$1.15

+-2.6% from low

Target vs 52W High

$16.87

+44.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%